This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

From guideline to clinic: early screening programs in gastroenterology and hepatology

  • Method validation
  • Precision dosing
  • Biomarker-guided therapy
  • Minimally invasive techniques

Date Published:

Abstract

In routine practice, variability between operators remains a key limitation, a finding echoed by several independent groups. When protocols are compared, pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups.

From a workflow perspective, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups. Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, pending validation in prospective studies. Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, as discussed in the accompanying commentary.

When protocols are compared, variability between operators remains a key limitation, and this trend is expected to continue. From a workflow perspective, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. According to consensus recommendations, patient selection criteria deserve closer scrutiny, a finding echoed by several independent groups. When protocols are compared, variability between operators remains a key limitation, as discussed in the accompanying commentary.

Background

Recent studies suggest that integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary. Longitudinal data show that patient selection criteria deserve closer scrutiny, which has direct implications for daily practice. Emerging evidence indicates that real-world registries complement randomized trial evidence, pending validation in prospective studies. Across multiple cohorts, pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups.

From a workflow perspective, threshold harmonization is still an open question, a finding echoed by several independent groups. When protocols are compared, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. Recent studies suggest that digital tooling shortens time-to-decision considerably, and this trend is expected to continue. Recent studies suggest that standardized reporting improves comparability between centers, a finding echoed by several independent groups. Across multiple cohorts, pre-analytical factors account for a large share of observed variance, pending validation in prospective studies.

Key considerations

According to consensus recommendations, cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. When protocols are compared, standardized reporting improves comparability between centers, pending validation in prospective studies. Recent studies suggest that patient selection criteria deserve closer scrutiny, and this trend is expected to continue. When protocols are compared, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups.

What the evidence shows

Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. When protocols are compared, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. According to consensus recommendations, standardized reporting improves comparability between centers, as discussed in the accompanying commentary.

References

  1. Tanaka et al. Sample preparation. J Gastroenterology and hepatology Res. 2023;12(4):492-1095.
  2. Tanaka et al. Combination therapy. J Gastroenterology and hepatology Res. 2024;33(11):176-1055.
  3. Tanaka et al. Combination therapy. J Gastroenterology and hepatology Res. 2025;32(11):466-1064.
  4. Haddad et al. Diagnostic imaging workflows. J Gastroenterology and hepatology Res. 2026;24(7):649-1076.